APA (7th ed.) Citation

SJ, N., S, J., S, C., S, K., F, J., PK, K., . . . DA, W. (2022). Discovery of BMS-986339, a Pharmacologically Differentiated Farnesoid X Receptor Agonist for the Treatment of Nonalcoholic Steatohepatitis. Journal of medicinal chemistry, 65(13), 8948. https://doi.org/10.1021/acs.jmedchem.2c00165

Chicago Style (17th ed.) Citation

SJ, Nara, et al. "Discovery of BMS-986339, a Pharmacologically Differentiated Farnesoid X Receptor Agonist for the Treatment of Nonalcoholic Steatohepatitis." Journal of Medicinal Chemistry 65, no. 13 (2022): 8948. https://doi.org/10.1021/acs.jmedchem.2c00165.

MLA (9th ed.) Citation

SJ, Nara, et al. "Discovery of BMS-986339, a Pharmacologically Differentiated Farnesoid X Receptor Agonist for the Treatment of Nonalcoholic Steatohepatitis." Journal of Medicinal Chemistry, vol. 65, no. 13, 2022, p. 8948, https://doi.org/10.1021/acs.jmedchem.2c00165.